BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1689683)

  • 1. Renal kallikrein and hemodynamic abnormalities of diabetic kidney.
    Harvey JN; Jaffa AA; Margolius HS; Mayfield RK
    Diabetes; 1990 Mar; 39(3):299-304. PubMed ID: 1689683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats.
    Jaffa AA; Silva RH; Kim B; Mayfield RK
    J Am Soc Nephrol; 1996 May; 7(5):721-7. PubMed ID: 8738807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary and renal tissue kallikrein in the streptozocin-diabetic rat.
    Mayfield RK; Margolius HS; Bailey GS; Miller DH; Sens DA; Squires J; Namm DH
    Diabetes; 1985 Jan; 34(1):22-8. PubMed ID: 3843806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats.
    Perico N; Benigni A; Gabanelli M; Piccinelli A; Ròg M; De Riva C; Remuzzi G
    Diabetes; 1992 Apr; 41(4):533-8. PubMed ID: 1535057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal kallikrein responses to dietary protein: a possible mediator of hyperfiltration.
    Jaffa AA; Harvey JN; Sutherland SE; Margolius HS; Mayfield RK
    Kidney Int; 1989 Dec; 36(6):1003-10. PubMed ID: 2601251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
    Jaffa AA; Rust PF; Mayfield RK
    Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney.
    Jaffa AA; Chai KX; Chao J; Chao L; Mayfield RK
    Kidney Int; 1992 Apr; 41(4):789-95. PubMed ID: 1513101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary active kallikrein excretion and diabetic renal impairments in streptozotocin-treated rats.
    Yasujima M; Yoshida K; Kanazawa M; Kohzuki M; Omata K; Watanabe H; Hiwatari M; Sato T; Abe K
    Tohoku J Exp Med; 1993 Oct; 171(2):135-44. PubMed ID: 8128482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.
    Esmatjes E; Fernandez MR; Halperin I; Camps J; Gaya J; Arroyo V; Rivera F; Figuerola D
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1231-6. PubMed ID: 3858281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
    Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
    Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of acute insulin infusion on renal function in awake nondiabetic and diabetic rats.
    Tucker BJ; Mendonca MM; Blantz RC
    J Am Soc Nephrol; 1993 Apr; 3(10):1686-93. PubMed ID: 8318685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats.
    Stackhouse S; Miller PL; Park SK; Meyer TW
    Diabetes; 1990 Aug; 39(8):989-95. PubMed ID: 2373266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy.
    Allen TJ; Cooper ME; O'Brien RC; Bach LA; Jackson B; Jerums G
    Diabetes; 1990 Oct; 39(10):1182-90. PubMed ID: 2170215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal kallikrein in human and experimental diabetes mellitus.
    Mayfield RK; Margolius HS; Shimojo N; Miller DH; Squires J; Namm DH
    Horm Metab Res Suppl; 1985; 15():31-7. PubMed ID: 3865881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of plasma, glandular and urinary kallikrein in renal hypertrophy in streptozotocin-diabetic rats.
    Sulaiman MI; Al-Fayz SF
    Acta Diabetol Lat; 1986; 23(3):253-9. PubMed ID: 3641509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
    Komers R; Allen TJ; Cooper ME
    Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in kallikrein excretion in spontaneously hypertensive rats.
    Ader JL; Pollock DM; Butterfield MI; Arendshorst WJ
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F396-403. PubMed ID: 3844907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function in the diabetic pregnant rats.
    Marina-Prendes MG; Zuccollo A; Catanzaro OL
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(2):65-70. PubMed ID: 10797842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hyperglycemia: a determinant factor for hypofiltration in alloxan diabetic rats.
    Di Loreto V; Moreno HS; Puche RC; Locatto ME
    Acta Diabetol; 2004 Jun; 41(2):56-62. PubMed ID: 15224206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.